X4 Pharmaceuticals, Inc. (XFOR) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript
Source: SeekingAlpha
2026-02-16 17:57:36 ET
X4 Pharmaceuticals, Inc. (XFOR) Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 12:30 PM EST...
Read the full article on Seeking Alpha
For further details see:
X4 Pharmaceuticals, Inc. (XFOR) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript
X4 Pharmaceuticals Inc.
NASDAQ: XFOR
XFOR Trading
12.65% G/L:
$4.63 Last:
644,014 Volume:
$4.21 Open:
XFOR Latest News
March 04, 2026 07:00:00 am
X4 Pharmaceuticals to Participate in a Fireside Chat at the Leerink Global Healthcare Conference
February 27, 2026 07:00:00 am
X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome
February 03, 2026 07:00:00 am
X4 Pharmaceuticals to Participate in Guggenheim's Emerging Outlook: Biotech Summit 2026
February 02, 2026 04:01:00 pm
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
XFOR Stock Data
$322,204,195
76,629,513
N/A
29
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
